Overview of vitiligo research October - December 2013

This is a review of research results in the vitiligo field for the period from October 2013 till December 2013 from our Chief Scientific Director Dr. Igor Korobko.


  • Central role of IFN-gamma but not that of TNF-alpha in vitiligo development is further confirmed.
  • Regulatory T-cell role in vitiligo pathogenesis demonstrated again.
  • Proton pump inhibitors might aggravate vitiligo. The first case of vitiligo induction upon gefitinib treatment is reported.
  • Additional evidence on efficient treatment of segmental vitiligo by routinely used non-surgical methods was provided, but early-after-onset disease treatment seems to be required for success.

The full report is available for download in pdf.

image description

I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.

To download this free file, please tell us a little bit about yourself.